Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering CorpfiledCriticalSchering Corp
Publication of ZA200608778BpublicationCriticalpatent/ZA200608778B/en
[1,2,4]triazolo[1,5-a]pyridine and [1,2,4]triazolo[1,5-c]pyrimidine derivatives as adenosine a2a receptor antagonists and pharmaceutical compositions containing them
Uses of 2-[piperidinyl]methyl-2,3-dihydroimidazo[1,2-c]quinazolin-5(6H)-one for providing an anti-allergic effect and histamine H1 receptor antagonism effect
Pyrazolo [4, 3‐e][1, 2, 4] triazolo [1, 5‐c] pyrimidines and Linked Heterocycles as Template for the Adenosine Receptor Antagonism: Medicinal Chemistry Approach and SAR Considerations